logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Arcturus Therapeutics, Inc.


USPTO Granted Patents = 65



Trademarks = 4

Forward Citations = 296

Loading Chart...
Loading Chart...

45 inventors (with patents filed for the assignee):

goldMedal Padmanabh Chivukula (54 out of 57 patents)

silverMedal Joseph E Payne (34 out of 56 patents)

bronzeMedal Kiyoshi Tachikawa (24 out of 27 patents)

4.  Priya Prakash Karmali (19 out of 33 patents)

5.  Steven Paul Tanis (13 out of 42 patents)

6.  Yanjie Bao (11 out of 12 patents)

7.  Daiki Matsuda (9 out of 9 patents)

8.  Pattraranee Limphong (7 out of 7 patents)

9.  Jesper Wengel (6 out of 8 patents)

10.  Amit Sagi (5 out of 5 patents)

11.  Arisa Cale (4 out of 4 patents)

12.  Jared Henry Davis (4 out of 4 patents)

13.  Sean Michael Sullivan (4 out of 4 patents)

14.  Carlos Gustavo Perez-Garcia (3 out of 5 patents)

15.  Christine Esau (3 out of 5 patents)


Core Competencies:
Nucleic Acid Vaccine
Lipid Formulation
RNA Delivery
Cationic Lipid
Therapeutic Oligomers
Immune Responses
RNA Nanoparticles
Gene Editing
Amino-LNA Oligonucleotides
Coronovirus Vaccines
Ornithine Transcarbamylase
Amyloidosis

65 patents:

1. 12723023 - Ionizable cationic lipids for RNA delivery (2026-09-01),
2. 12637422 - Ionizable cationic lipid for RNA delivery (2026-05-26),
3. 12533410 - Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines (2026-01-27),
4. 12527881 - Ionizable cationic lipid for RNA delivery (2026-01-20),
5. 12509698 - SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS (2025-12-30),
6. RE50681 - Ionizable cationic lipid for RNA delivery (2025-12-02),
7. 12398379 - Compositions and methods for treating ornithine transcarbamylase deficiency (2025-08-26),
8. 12390524 - Compositions and methods for inducing immune responses (2025-08-19),
9. 12351834 - Compositions and methods for the treatment of ornithine transcarbamylase deficiency (2025-07-08),
10. 12290567 - Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates (2025-05-06),
11. 12286395 - Method of synthesis of an ionizable cationic lipid (2025-04-29),
12. 12220485 - Method of making lipid-encapsulated RNA nanoparticles (2025-02-11),
13. 12220455 - Coronavirus vaccine compositions and methods (2025-02-11),
14. 12178921 - Method of lyophilizing lipid nanoparticles (2024-12-31),
15. 12083224 - Lipid particles for nucleic acid delivery (2024-09-10),
Arcturus Therapeutics, Inc. is a biotechnology company based in San Diego, California, specializing in RNA therapeutics. The company focuses on developing innovative solutions in nucleic acid vaccines and RNA delivery systems, leveraging advanced lipid formulations and cationic lipids. Arcturus is dedicated to enhancing immune responses through its proprietary RNA nanoparticles and therapeutic oligomers, aiming to address a range of diseases through cutting-edge gene editing technologies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Arcturus Therapeutics, Inc.
65 Patents

#96 in San Diego, CA

#1,300 in California

#5,601 in US

#11,312 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Arcturus Therapeutics, Inc.

Forward Citations = 296

45 inventors:

goldMedal Padmanabh Chivukula (54 out of 57 patents)

silverMedal Joseph E Payne (34 out of 56 patents)

bronzeMedal Kiyoshi Tachikawa (24 out of 27 patents)

4.  Priya Prakash Karmali (19 out of 33 patents)

5.  Steven Paul Tanis (13 out of 42 patents)

Please report any incorrect information to [email protected]
Loading…